Precision Biosciences (DTIL) EBT Margin Growth (5y) (2023 - 2026)
Precision Biosciences (DTIL) EBT Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,926.00 |
| Dec 31, 2025 | 31,083.00 |
| Sep 30, 2025 | -21.23 Mn |
| Jun 30, 2025 | -11.99 Mn |
| Mar 31, 2025 | -7.29 Mn |
| Dec 31, 2024 | -341,755.00 |
| Sep 30, 2024 | -463,306.00 |
| Jun 30, 2024 | 51,604.00 |
| Mar 31, 2024 | 39,679.00 |
| Dec 31, 2023 | 12,810.00 |
| Sep 30, 2023 | 30,170.00 |
| Jun 30, 2023 | 59,274.00 |
| Mar 31, 2023 | 45,445.00 |